Protagonist Therapeutics, Inc reports

Company location: Newark, CA
Fiscal year end: 31 December

Protagonist Therapeutics, Inc has filed 702 SEC EDGAR filings since 28 Sep 2006

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 276-300 of 701 matching filings.

Per page

25

Current page

12

SC 13G/A File 005-89601

SC 13G/A filing

Filing date: 09 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G File 005-89601

SCHEDULE 13G

Filing date: 09 Feb 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-89601

SC 13G/A filing

Filing date: 31 Jan 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 18 Jan 2023
Reporting date: 16 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 18 Jan 2023
Reporting date: 16 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 18 Jan 2023
Reporting date: 16 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 18 Jan 2023
Reporting date: 16 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 18 Jan 2023
Reporting date: 16 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 18 Jan 2023
Reporting date: 16 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 18 Jan 2023
Reporting date: 16 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 18 Jan 2023
Reporting date: 16 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 18 Jan 2023
Reporting date: 16 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 18 Jan 2023
Reporting date: 16 Jan 2023
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-89601

SCHEDULE 13G/A FOR PROTAGONIST THERAPEUTICS, INC. ON BEHALF OF JOHNSON & JOHNSON

Filing date: 11 Jan 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-89601

SC 13G/A filing

Filing date: 10 Jan 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-37852

FORM 8-K

Filing date: 06 Jan 2023
Reporting date: 01 Jan 2023
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

SC 13G File 005-89601

SC 13G

Filing date: 03 Jan 2023
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

SC 13G/A File 005-89601

SC 13G/A filing

Filing date: 12 Dec 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 17 Nov 2022
Reporting date: 16 Nov 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

4

OWNERSHIP DOCUMENT

Filing date: 17 Nov 2022
Reporting date: 15 Nov 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

3

OWNERSHIP DOCUMENT

Filing date: 17 Nov 2022
Reporting date: 07 Nov 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

10-Q File 001-37852

10-Q

Filing date: 08 Nov 2022
Reporting date: 30 Sep 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

8-K File 001-37852

FORM 8-K

Filing date: 08 Nov 2022
Reporting date: 08 Nov 2022
SEC evidence: Open document Open filing Open XBRL
Next action: Verify source filing

4

FORM 4 SUBMISSION

Filing date: 24 Aug 2022
Reporting date: 23 Aug 2022
SEC evidence: Open document Open filing
Next action: Verify source filing

EFFECT File 333-266595

EFFECT filing

Filing date: 16 Aug 2022
Reporting date: Not listed
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .